Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 73.41 -0.05%   SPY: 165.31 -0.09%
Quote Spy NVS NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Novartis AG (NVS)

@ May-24
Click the portfolio to add NVS:
Close [X]
+ Add NVS to Portfolio
  
  Last Trade: $74.36 +0.54 (0.73%)
  Volume: 1,008,886 69% of avg daily volume
       
  Avg Volume: 1,460,588
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 73.85 - 74.43
  Open: 74.36
  Previous Close: 73.82
  52-wk Range: 51.35 - 75.73
  Market Cap: 182.7B
  P/E: 19.0
  Div Yield: $2.06 (2.79%)
Indexes
Generic Drug Stocks (-0.4%)
Swine Flu and Bird F... (-0.1%)
Switzerland Stocks a... (+0.7%)
Spy NVS

? Pro holders
? Member holders
? Items submitted
Additional NVS resources



Customize Links
To see which Pros and tickerspy members own NVS Sign up now
Latest NVS Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Biogen-Novartis MS Drug Fight Hits Social Media
BIIB  NVS  
Linked by YCHARTS - May 23, 02:23PM from (ycharts.com)
Over the past month, the track record for the newly launched Tecfidera multiple sclerosis pill has become a closely watched  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Teva Still Too Cheap, But Still Too Uncertain
MYL  TEVA  ACT  NVS  
Linked by Investopedia Stock Analysis - May 03, 01:45PM from (www.investopedia.com)
Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
$50,000-a-Year MS Drugs: Pharma Growth Battle
BIIB  NVS  SNY  
Linked by YCHARTS - May 01, 04:32PM from (ycharts.com)
Here is one way to tell that the battle in the multiple sclerosis market is heating up. Now that Biogen Idec (BIIB) has successfully  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Biogen Stock Up on New MS Drug Sales
BIIB  NVS  SNY  
Linked by YCHARTS - April 29, 03:21PM from (ycharts.com)
File this under 'so far, so good.' In one of the more impressive showings for a new medicine, the Tecfidera multiple sclerosis  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
U.S. Files 2nd Suit Accusing Novartis of Kickbacks to Doctors
NVS  
Linked by NYTimes - April 26, 09:33PM from (www.nytimes.com)
The government joined a whistle-blower lawsuit that said a unit of Novartis paid millions to doctors in exchange for prescribing  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
U.S. Files Second Lawsuit Against Novartis
NVS  
Linked by NYTimes - April 26, 03:36PM from (www.nytimes.com)
In its second civil fraud lawsuit against Novartis in four days, the government joined a whistle-blower suit accusing a unit  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Short Sellers Move into Celgene, Regeneron
BMY  JNJ  MRK  AMGN  CELG  REGN  BIIB  VRTX  VVUS  GILD  ALXN  PCYC  ONXX  ARNA  DNDN  ILMN  NVS  
Linked by Benzinga.com - April 26, 01:25PM from (www.benzinga.com)
The short interest moves in biotech and emerging pharmaceutical companies were mixed in the first two weeks of April.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Cancer Physicians Attack High Drug Costs
BMY  PFE  NVS  SNY  
Linked by NYTimes - April 25, 10:03AM from (www.nytimes.com)
More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
U.S. Accuses Novartis of Providing Kickbacks
NVS  
Linked by NYTimes - April 23, 09:40PM from (www.nytimes.com)
A lawsuit accuses the drug company of giving pharmacies discounts in exchange for promoting a drug.<img width='1' height='1'  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
U.S. Sues Novartis Over Alleged Fraudulent Kickbacks
NVS  
Linked by NYTimes - April 23, 04:56PM from (www.nytimes.com)
The lawsuit accuses the Swiss drug maker of using kickbacks to induce pharmacies to steer thousands of patients to its drug  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 53



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource